Literature DB >> 1832663

Role of L3T4-bearing T-cell populations in experimental murine chlamydial salpingitis.

D V Landers1, K Erlich, M Sung, J Schachter.   

Abstract

A role for both the cellular and humoral components of the immune response has been established for chlamydial infection. The significance of helper (L3T4) T cells was evaluated by using a Chlamydia trachomatis murine salpingitis model for upper genital tract chlamydial infection. Mouse oviducts were inoculated with C. trachomatis by using the mouse pneumonitis agent (MoPn) or control medium. Mice depleted of L3T4-bearing lymphocytes had significantly higher (P less than 0.05) numbers of organisms recovered at day 7 postinoculation. The rate of hydrosalpinx formation was significantly higher in the mice depleted of L3T4-bearing lymphocytes (27 of 31 [87%] ) than in the infected undepleted group (8 of 16 [50%] ) (P less than 0.01). The geometric mean antichlamydial immunoglobulin G titers at day 54 postinoculation were significantly higher in the L3T4-depleted mice (mean titer, 2,030) than in the undepleted group (mean titer, 776; P less than 0.05). The rate of fertility was lower in the L3T4-depleted group (2 of 31 [6%]) than in the infected, undepleted mice (2 of 16 [13%]), but this difference did not reach statistical significance. In conclusion, the greater persistence of organisms in the oviduct and higher rates of hydrosalpinx formation in mice depleted of L3T4-bearing cells suggests that these cells play a role in the clearing of organisms following infection and thus in reducing the degree of oviduct obstruction and damage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1832663      PMCID: PMC258950          DOI: 10.1128/iai.59.10.3774-3777.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Serologic evidence for the role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy.

Authors:  A Miettinen; P K Heinonen; K Teisala; K Hakkarainen; R Punnonen
Journal:  Sex Transm Dis       Date:  1990 Jan-Mar       Impact factor: 2.830

Review 2.  Human immune response and Chlamydia trachomatis infection.

Authors:  D Kunimoto; R C Brunham
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

3.  Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease.

Authors:  D E Moore; L R Spadoni; H M Foy; S P Wang; J R Daling; C C Kuo; J T Grayston; D A Eschenbach
Journal:  Lancet       Date:  1982-09-11       Impact factor: 79.321

4.  Cellular immunity to the mouse pneumonitis agent.

Authors:  D M Williams; J Schachter; J J Coalson; B Grubbs
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226

5.  Both species of chlamydia and two biovars of Chlamydia trachomatis stimulate mouse B lymphocytes.

Authors:  D Levitt; R Danen; J Bard
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

6.  Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial-conjunctivitis in guinea pigs.

Authors:  N G Watkins; W J Hadlow; A B Moos; H D Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

7.  Chlamydia trachomatis-induced salpingitis in mice.

Authors:  C E Swenson; E Donegan; J Schachter
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

8.  Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H Su; R P Morrison; N G Watkins; H D Caldwell
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

9.  Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

Authors:  D Wofsy; W E Seaman
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

10.  Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein.

Authors:  R P Morrison; K Lyng; H D Caldwell
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  27 in total

1.  Chlamydial colonization of multiple mucosae following infection by any mucosal route.

Authors:  L L Perry; S Hughes
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

Review 2.  Immunity to murine chlamydial genital infection.

Authors:  Richard P Morrison; Harlan D Caldwell
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

4.  Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.

Authors:  Weidang Li; Ashlesh K Murthy; M Neal Guentzel; James P Chambers; Thomas G Forsthuber; J Seshu; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

Review 5.  Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Authors:  Christina M Farris; Richard P Morrison
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

6.  Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.

Authors:  Ashlesh K Murthy; James P Chambers; Patricia A Meier; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

7.  CCR7 Deficiency Allows Accelerated Clearance of Chlamydia from the Female Reproductive Tract.

Authors:  Lin-Xi Li; Jasmine C Labuda; Denise M Imai; Stephen M Griffey; Stephen J McSorley
Journal:  J Immunol       Date:  2017-08-11       Impact factor: 5.422

8.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo.

Authors:  S C Knight; S Iqball; C Woods; A Stagg; M E Ward; M Tuffrey
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

10.  Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.

Authors:  R P Morrison; K Feilzer; D B Tumas
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.